Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: Antibiotics alone or combined antibiotics/immunomodulators?

Inflammatory Bowel Diseases

Volumn 17, Issue 7, 2011, Pages 1540-1546

  Yanai, Henit ^a   Nguyen, Geoffrey C ^b   Yun, Laura ^c   Lebwohl, Oscar ^d   Navaneethan, Udayakumar ^e   Stone, Christian D ^f   Ghazi, Leyla ^g   Moayyedi, Paul ^h   Brooks, Jeffrey ⁱ   Bernstein, Charles N ^j   Ben Horin, Shomron ^k,l  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^h MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

ⁱ UNIVERSITY OF NORTH DAKOTA   (United States)

^j UNIVERSITY OF MANITOBA   (Canada)

^k TEL AVIV UNIVERSITY   (Israel)

^l SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

Clostridium difficile; Crohn's disease; infection; ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; MESALAZINE; METRONIDAZOLE; STEROID; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE EXACERBATION; DRUG CHOICE; ENTERITIS; GASTROENTEROLOGIST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL SPECIALIST; NORMAL HUMAN; NORTH AMERICA; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG THERAPY, COMBINATION; GASTROENTEROLOGY; HUMANS; IMMUNOLOGIC FACTORS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES;

EID: 79958795293     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21514     Document Type: Article

References (25)

1. Meyer AM, Ramzan NN, Loftus EV Jr, et al. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol. 2004; 38: 772-775. (Pubitemid 39274178)
2. Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004; 16: 775-778. (Pubitemid 39062569)
3. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008; 103: 1443-1450. (Pubitemid 351813903)
4. Clayton EM, Rea MC, Shanahan F, et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol. 2009; 104: 1162-1169.
5. Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 339-344. (Pubitemid 46401530)
6. Ananthakrishnan AN, McGinley EL, Binion DG., Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008; 57: 205-210. (Pubitemid 351158048)
7. McFarland LV., Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 40-48.
8. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007; 45: 302-307. (Pubitemid 47101025)
9. Ananthakrishnan AN, Binion DG., Clostridium difficile and inflammatory bowel disease: more questions than answers? Inflamm Bowel Dis. 2010; 16: 1445-1446.
10. Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohn's Colitis. 2009; 3: 4-7.
11. Ben-Horin S, Margalit M, Bossuyt P, et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol. 2009; 7: 981-987.
12. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 345-351. (Pubitemid 46401531)
13. Pascarella F, Martinelli M, Miele E, et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr. 2009; 154: 854-858.
14. Kim KA, Wry P, Hughes E Jr, et al. Clostridium difficile small-bowel enteritis after total proctocolectomy: a rare but fatal, easily missed diagnosis. Report of a case. Dis Colon Rectum. 2007; 50: 920-923. (Pubitemid 46870438)
15. Shen BO, Jiang ZD, Fazio VW, et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008; 6: 782-788.
16. Ben-Horin S, Margalit M, Bossuyt P, et al. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohn's Colitis. 2010; 4: 194-198.
17. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002; 235: 363-372. (Pubitemid 34183887)
18. Gellad ZF, Alexander BD, Liu JK, et al. Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. Transpl Infect Dis. 2007; 9: 276-280. (Pubitemid 350059151)
19. Hardt C, Berns T, Treder W, et al. Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol. 2008; 14: 4338-4341.
20. Henrich TJ, Krakower D, Bitton A, et al. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis. 2009; 15: 415-422.
21. Lamontagne F, Labbe AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007; 245: 267-272. (Pubitemid 46148486)
22. Rubin MS, Bodenstein LE, Kent KC., Severe Clostridium difficile colitis. Dis Colon Rectum. 1995; 38: 350-354.
23. Ricciardi R, Ogilvie JW Jr, Roberts PL, et al. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum. 2009; 52: 40-45.
24. Kelsen JR, Latta DR, Zaoutis T, et al. Rate of recurrence of Clostridium difficile in pediatric patients with inflammatory bowel disease. Gastroenterology. 2009; 136: A-14.
25. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn's Colitis. 2009; 3: 47-91.